ACTU Actuate Therapeutics, Inc.
Fundamentals / CIK 0001652935 / USDActuate Therapeutics, Inc. reported $3.22M in total assets and a net loss of $18.47M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ACTU in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$18.74M Operating profit
-
Net Income FY 2025-$18.47M GAAP bottom line
-
Diluted EPS FY 2025-$0.76 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$2.10M Total debt: --
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Research & Development | $10.29M | $18.68M | $21.71M |
| Total Operating Expenses | $22.50M | $25.16M | $24.97M |
| Operating Income | -$22.50M | -$25.16M | -$24.97M |
| Interest Income | $288K | $222K | $353K |
| Interest Expense | $20K | $19K | $44K |
| Income Tax Expense | $800 | $800 | $0 |
| Net Income | -$22.23M | -$27.29M | -$24.74M |
| Basic EPS | -$1.06 | -$3.26 | -$17.24 |
| Diluted EPS | -$1.06 | -$3.26 | -$17.24 |
| Basic Shares Outstanding | 21.0M | 8.4M | 1.4M |
| Diluted Shares Outstanding | 21.0M | 8.4M | 1.4M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $1.81M | $2.07M | $2.57M | $2.13M | $2.18M | $2.76M | $3.22M | $3.69M |
| Total Operating Expenses | $3.44M | $4.91M | $5.71M | $4.69M | $5.47M | $5.97M | $6.37M | $6.56M |
| Operating Income | -$3.44M | -$4.91M | -$5.71M | -$4.69M | -$5.47M | -$5.97M | -$6.37M | -$6.56M |
| Interest Income | -- | $45K | $85K | $140K | $70K | $25K | $54K | $118K |
| Interest Expense | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K |
| Net Income | -$3.42M | -$4.87M | -$5.63M | -$4.55M | -$5.41M | -$5.95M | -$6.32M | -$6.45M |
| Basic EPS | -$0.14 | -$0.20 | -$0.24 | -- | -$0.25 | -$0.30 | -$0.32 | -- |
| Diluted EPS | -$0.14 | -$0.20 | -$0.24 | -- | -$0.25 | -$0.30 | -$0.32 | -- |
| Basic Shares Outstanding | 24.2M | 23.9M | 23.5M | -- | 21.4M | 19.6M | 19.5M | -- |
| Diluted Shares Outstanding | 24.2M | 23.9M | 23.5M | -- | 21.4M | 19.6M | 19.5M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $13.16M | $8.64M | -- |
| Cash & Short-Term Investments | $13.16M | $8.64M | -- |
| Total Current Assets | $13.64M | $9.21M | $3.00M |
| Other Non-Current Assets | $392K | $111K | $0 |
| Total Non-Current Assets | $392K | $111K | $0 |
| Total Assets | $14.04M | $9.32M | $3.00M |
| Accounts Payable | $1.52M | $1.92M | $3.42M |
| Total Current Liabilities | $5.71M | $8.80M | $6.92M |
| Total Non-Current Liabilities | $405K | $412K | $1.52M |
| Total Liabilities | $6.11M | $9.21M | $8.44M |
| Common Stock | $23 | $20 | $2 |
| Retained Earnings | -$154.6M | -$132.4M | -$105.1M |
| Total Stockholders' Equity | $7.92M | $104K | -$99.63M |
| Total Equity | $7.92M | $104K | -$99.63M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $2.10M | $4.43M | $8.13M | $13.16M | $16.92M | $6.49M | $3.89M | $8.64M |
| Cash & Short-Term Investments | $2.10M | $4.43M | $8.13M | $13.16M | $16.92M | $6.49M | $3.89M | $8.64M |
| Total Current Assets | $2.65M | $4.75M | $8.52M | $13.64M | $17.44M | $6.69M | $4.25M | $9.21M |
| Other Non-Current Assets | $571K | $451K | $392K | $392K | $270K | $280K | $234K | $111K |
| Total Non-Current Assets | $571K | $451K | $392K | $392K | $270K | $280K | $234K | $111K |
| Total Assets | $3.22M | $5.20M | $8.91M | $14.04M | $17.71M | $6.97M | $4.48M | $9.32M |
| Accounts Payable | $891K | $1.08M | $1.20M | $1.52M | $1.25M | $3.17M | $2.64M | $1.92M |
| Total Current Liabilities | $3.62M | $3.81M | $4.72M | $5.71M | $6.37M | $9.20M | $9.15M | $8.80M |
| Total Non-Current Liabilities | $405K | $405K | $405K | $405K | $405K | $422K | $417K | $412K |
| Total Liabilities | $4.03M | $4.21M | $5.13M | $6.11M | $6.78M | $9.62M | $9.57M | $9.21M |
| Common Stock | $25 | $24 | $24 | $23 | $23 | $20 | $20 | $20 |
| Retained Earnings | -$168.5M | -$165.1M | -$160.2M | -$154.6M | -$150.1M | -$144.6M | -$138.7M | -$132.4M |
| Total Stockholders' Equity | -$809K | $989K | $3.78M | $7.92M | $10.94M | -$2.65M | -$5.09M | $104K |
| Total Equity | -$809K | $989K | $3.78M | $7.92M | $10.94M | -$2.65M | -$5.09M | $104K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$22.23M | -$27.29M | -$24.74M |
| Stock-Based Compensation | $6.05M | $2.00M | $424K |
| Change in Payables | -$513K | -$1.50M | $1.29M |
| Operating Cash Flow | -$19.21M | -$21.84M | -$21.63M |
| Common Stock Issued | $3.83M | $0 | -- |
| Financing Cash Flow | $23.72M | $27.53M | $4.13M |
| Net Change in Cash | $4.52M | $5.68M | -$17.49M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$3.42M | -$4.87M | -$5.63M | -$4.55M | -$5.41M | -$5.95M | -$6.32M | -$6.45M |
| Stock-Based Compensation | $971K | $1.34M | $1.36M | $1.54M | $1.80M | $1.58M | $1.13M | $1.19M |
| Change in Payables | -$280K | -$151K | -$323K | $186K | -$1.83M | $508K | $622K | -$303K |
| Operating Cash Flow | -$2.95M | -$4.41M | -$5.02M | -$3.74M | -$6.68M | -$4.17M | -$4.62M | -$4.77M |
| Common Stock Issued | $774K | $732K | $520K | $3.83M | $0 | $0 | $0 | -- |
| Financing Cash Flow | $627K | $697K | -$8.1K | -$29K | $17.11M | $6.78M | -$133K | -$109K |
| Net Change in Cash | -$2.32M | -$3.71M | -$5.03M | -$3.77M | $10.43M | $2.60M | -$4.75M | -$4.88M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Return on Equity (ROE) | -280.5% | -26189.1% | -- |
| Return on Assets (ROA) | -158.4% | -292.8% | -826.0% |
| Current Ratio | 2.39x | 1.05x | 0.43x |
| Quick Ratio | 2.31x | 0.98x | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -2067.8% | -569.1% | -280.5% | -220.6% | -- | -- | -26189.1% |
| Return on Assets (ROA) | -573.7% | -393.4% | -241.7% | -158.4% | -136.2% | -354.2% | -564.5% | -292.8% |
| Current Ratio | 0.73x | 1.25x | 1.80x | 2.39x | 2.74x | 0.73x | 0.46x | 1.05x |
| Quick Ratio | 0.58x | 1.16x | 1.72x | 2.31x | 2.66x | 0.71x | 0.42x | 0.98x |